New Technique Could Spare Cancer Patients from Further Surgery

EU-funded researchers have developed a technique that could allow surgeons to distinguish between cancerous and healthy tissue in real time as they carry out operations. The novel technique, which is described in an article in the journal Angewandte Chemie International Edition, could spare cancer patients from having to undergo a second round of surgery to remove tumour tissue that was missed during the first operation.

EU support for the work came from the DESI_JEDI-IMAGING (Development of mass spectrometric techniques for three-dimensional imaging and in-vivo analysis of biological tissues) project, which received a EUR 1.75 million grant from the European Research Council (ERC) under the Seventh Framework Programme (FP7).

Surgery is a common tool in cancer treatment. Tissue removed during an operation is sent to the laboratory for analysis to ensure that all of the diseased tissue has been removed. Currently, it takes several days to examine the tissue; if it turns out that some diseased tissue has been left in the patient, he or she may require a second operation.

The starting point of the new technique is electrosurgery. In electrosurgery, the conventional scalpel is replaced with an electroscalpel, in which a high-frequency electrical current is used to cut through and remove tissue. An advantage of electrosurgery is that while a cut is being made, blood vessels are closed off, thereby avoiding excessive bleeding.

As the surgeon works, the treated tissue becomes extremely hot and is partially vaporised. In addition, the electrical current triggers the production of electrically charged molecules. Different types of tissue have different molecular profiles, and, crucially, the molecular profile of cancerous tissue looks very different to that of healthy tissue.

In this latest study, German and Hungarian researchers fitted a conventional electroscalpel with a special pump that sucks up the vaporised molecules and sends them to a mass spectrometer. Here, the molecular profile of the tissue being cut is analysed and the information is provided to the surgeon in real time. The researchers have dubbed their new technique REIMS (rapid evaporation ionisation mass spectrometry).

"Tissue analysis with REIMS, including data analysis, requires only fractions of a second," commented Dr Zoltán Takáts of Justus Liebig University in Germany. "During an operation, the surgeon thus received virtually real-time information about the nature of the tissue as he was cutting it." Furthermore, the system was able to tell the surgeon whether the cancer was at an early or advanced stage.

"The presented results serve as a basis for future development of surgical methods guided by mass spectrometry," the researchers write. "REIMS allows rapid analysis of vital and processed tissues and real-time identification of tissue features during surgery."

Although the system has not yet been tested on humans, the researchers point out that all the experiments were carried out under the conditions required for human surgical facilities. They are therefore optimistic that the new technique could be easily transferred to the operating theatre.

For furhter information, please visit:

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...